The global market for Postpartum Hemorrhage (PPH) Treatment Devices was valued at US$851.9 Million in 2024 and is projected to reach US$1.1 Billion by 2030, growing at a CAGR of 4.6% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Postpartum Hemorrhage (PPH) Treatment Devices market.
Technological advancements have led to the development of more effective and user-friendly devices, which are being increasingly adopted in both developed and developing countries. Uterine balloon tamponades, such as the Bakri balloon, have become standard in many medical settings due to their effectiveness and ease of use. These devices can be rapidly deployed and are minimally invasive, making them suitable for use in diverse healthcare environments, including low-resource settings. Electrosurgical devices and hemostatic agents have also evolved, offering precise and effective means to control bleeding. Non-pneumatic anti-shock garments, which apply circumferential pressure to reduce blood loss and maintain vital organ perfusion, are increasingly used in emergency settings, particularly in developing countries. The integration of these devices with digital monitoring systems allows for real-time assessment and management of blood loss, improving patient outcomes.
The growth in the PPH treatment devices market is driven by several factors, including rising global incidence of PPH and the growing awareness about maternal health. Rising complications concerning pregnancy, namely large-sized babies, multiple pregnancies, and inverted uterus are also fueling market growth. Further, increase in other risk factors of PPH, like traumatic uterine and uterine atony, an increase in pregnant women with anemia conditions, and rising awareness concerning PPH risks boost the market growth of postpartum hemorrhage devices. The expanding healthcare infrastructure, especially in emerging economies, has facilitated greater access to these advanced treatment options. Moreover, government initiatives and funding aimed at reducing maternal mortality rates have bolstered market growth. The demand for minimally invasive and easy-to-use devices that can be employed in a variety of healthcare settings, from tertiary care hospitals to rural clinics, has also spurred innovation in this field. These factors collectively ensure the robust expansion of the market, addressing a critical need in maternal healthcare.
Segments: Segment (Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG), Uniject Prefilled Injection System).
Geographic Regions/Countries: World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Brazil; Rest of Latin America; Middle East; Africa.
The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
Global Postpartum Hemorrhage (PPH) Treatment Devices Market - Key Trends & Drivers Summarized
Postpartum hemorrhage (PPH), also termed as postpartum bleeding, is a medical complication characterized by loss of over 500ml or 1,000ml of blood in women within the initial 24 hours after childbirth. Prevalent across both developed and developing countries, the condition is linked with a large number of mortalities. Uterine massage is considered as the first line treatment for ensuring contraction of the uterus and reducing bleeding. On the other hand, various medical professionals rely on non-pneumatic anti-shock garment (NASG) for delivery outside a healthcare setting. The approach improves shock in the pregnant women with obstetrical bleeding, providing the rime to reach hospital. Uterine balloon tamponades are also used for treating PPH among patients who are unresponsive to primary interventions and uterotonics. Uterine balloon tamponade hold potential to considerable improve the condition. In addition, inflating the Sengstaken-Blakemore tube in uterus can treat atonic PPH in majority of cases.Technological advancements have led to the development of more effective and user-friendly devices, which are being increasingly adopted in both developed and developing countries. Uterine balloon tamponades, such as the Bakri balloon, have become standard in many medical settings due to their effectiveness and ease of use. These devices can be rapidly deployed and are minimally invasive, making them suitable for use in diverse healthcare environments, including low-resource settings. Electrosurgical devices and hemostatic agents have also evolved, offering precise and effective means to control bleeding. Non-pneumatic anti-shock garments, which apply circumferential pressure to reduce blood loss and maintain vital organ perfusion, are increasingly used in emergency settings, particularly in developing countries. The integration of these devices with digital monitoring systems allows for real-time assessment and management of blood loss, improving patient outcomes.
The growth in the PPH treatment devices market is driven by several factors, including rising global incidence of PPH and the growing awareness about maternal health. Rising complications concerning pregnancy, namely large-sized babies, multiple pregnancies, and inverted uterus are also fueling market growth. Further, increase in other risk factors of PPH, like traumatic uterine and uterine atony, an increase in pregnant women with anemia conditions, and rising awareness concerning PPH risks boost the market growth of postpartum hemorrhage devices. The expanding healthcare infrastructure, especially in emerging economies, has facilitated greater access to these advanced treatment options. Moreover, government initiatives and funding aimed at reducing maternal mortality rates have bolstered market growth. The demand for minimally invasive and easy-to-use devices that can be employed in a variety of healthcare settings, from tertiary care hospitals to rural clinics, has also spurred innovation in this field. These factors collectively ensure the robust expansion of the market, addressing a critical need in maternal healthcare.
Report Scope
The report analyzes the Postpartum Hemorrhage (PPH) Treatment Devices market, presented in terms of units. The analysis covers the key segments and geographic regions outlined below.Segments: Segment (Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG), Uniject Prefilled Injection System).
Geographic Regions/Countries: World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Brazil; Rest of Latin America; Middle East; Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Uterine Balloon Tamponade segment, which is expected to reach US$521.7 Million by 2030 with a CAGR of a 4.3%. The Non-Pneumatic Anti-Shock Garment (NASG) segment is also set to grow at 4.6% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $289.6 Million in 2024, and China, forecasted to grow at an impressive 6.1% CAGR to reach $146.8 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Postpartum Hemorrhage (PPH) Treatment Devices Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Postpartum Hemorrhage (PPH) Treatment Devices Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Postpartum Hemorrhage (PPH) Treatment Devices Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as 3RD Stone Design, Inc., Cook Medical LLC, Laborie Medical Technologies Corporation, Organon & Co., Sinapi Biomedical and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 26 companies featured in this Postpartum Hemorrhage (PPH) Treatment Devices market report include:
- 3RD Stone Design, Inc.
- Cook Medical LLC
- Laborie Medical Technologies Corporation
- Organon & Co.
- Sinapi Biomedical
- Utah Medical Products, Inc.
Tariff Impact Analysis: Key Insights for 2025
Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
What’s Included in This Edition:
- Tariff-adjusted market forecasts by region and segment
- Analysis of cost and supply chain implications by sourcing and trade exposure
- Strategic insights into geographic shifts
Buyers receive a free July 2025 update with:
- Finalized tariff impacts and new trade agreement effects
- Updated projections reflecting global sourcing and cost shifts
- Expanded country-specific coverage across the industry
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISSOUTH KOREAREST OF ASIA-PACIFICBRAZILREST OF LATIN AMERICAIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
SPAIN
RUSSIA
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3RD Stone Design, Inc.
- Cook Medical LLC
- Laborie Medical Technologies Corporation
- Organon & Co.
- Sinapi Biomedical
- Utah Medical Products, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 207 |
| Published | May 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 851.9 Million |
| Forecasted Market Value ( USD | $ 1100 Million |
| Compound Annual Growth Rate | 4.6% |
| Regions Covered | Global |
